|
WO2008078100A2
(en)
|
2006-12-22 |
2008-07-03 |
Astex Therapeutics Limited |
Tricyclic amine derivatives as protein tyrosine kinase inhibitors
|
|
AR064491A1
(es)
|
2006-12-22 |
2009-04-08 |
Astex Therapeutics Ltd |
Derivados de imidazo[1, 2-a]pirimidina, un proceso para su preparacion, una composicion farmaceutica que los comprende y su uso en el tratamiento de enfermedades mediadas por las quinasas fgfr.
|
|
ES2602615T3
(es)
|
2007-06-12 |
2017-02-21 |
Achaogen, Inc. |
Agentes antibacterianos
|
|
GB0720041D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New Compounds
|
|
GB0720038D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New compounds
|
|
US20110092554A1
(en)
*
|
2007-11-19 |
2011-04-21 |
Richard Chesworth |
1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
|
|
CN101945848A
(zh)
|
2007-12-20 |
2011-01-12 |
英维沃医药有限公司 |
四取代的苯
|
|
WO2009102893A2
(en)
|
2008-02-14 |
2009-08-20 |
Amira Pharmaceuticals, Inc. |
CYCLIC DIARYL ETHER COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 receptors
|
|
US8426449B2
(en)
|
2008-04-02 |
2013-04-23 |
Panmira Pharmaceuticals, Llc |
Aminoalkylphenyl antagonists of prostaglandin D2 receptors
|
|
UA103319C2
(en)
|
2008-05-06 |
2013-10-10 |
Глаксосмитклайн Ллк |
Thiazole- and oxazole-benzene sulfonamide compounds
|
|
GB0810902D0
(en)
|
2008-06-13 |
2008-07-23 |
Astex Therapeutics Ltd |
New compounds
|
|
CA2728210A1
(en)
*
|
2008-06-25 |
2009-12-30 |
Schering Corporation |
Synthesis and use of heterocyclic antibacterial agents
|
|
EP2307362A4
(en)
|
2008-07-03 |
2012-05-09 |
Panmira Pharmaceuticals Llc |
ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
|
|
US8273900B2
(en)
|
2008-08-07 |
2012-09-25 |
Novartis Ag |
Organic compounds
|
|
US8372885B2
(en)
*
|
2008-09-17 |
2013-02-12 |
Novartis Ag |
Organic compounds and their uses
|
|
US8383654B2
(en)
|
2008-11-17 |
2013-02-26 |
Panmira Pharmaceuticals, Llc |
Heterocyclic antagonists of prostaglandin D2 receptors
|
|
GB0906470D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
|
GB0906472D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
|
WO2011005355A1
(en)
*
|
2009-05-07 |
2011-01-13 |
Achaogen, Inc. |
Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria
|
|
FR2950057B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
FR2950056B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
CA2777739A1
(en)
|
2009-10-16 |
2011-04-21 |
Rib-X Pharmaceuticals, Inc. |
Antimicrobial compounds and methods of making and using the same
|
|
EA023350B1
(ru)
|
2009-10-16 |
2016-05-31 |
Мелинта Терапьютикс, Инк. |
Противомикробные соединения, способы их получения и применение
|
|
CN102712647B
(zh)
|
2009-10-16 |
2018-04-24 |
梅琳塔治疗公司 |
抗微生物化合物和其制备和使用方法
|
|
SG182398A1
(en)
|
2010-01-06 |
2012-08-30 |
Panmira Pharmaceuticals Llc |
Dp2 antagonist and uses thereof
|
|
TW201609079A
(zh)
|
2010-04-20 |
2016-03-16 |
大正製藥股份有限公司 |
新穎之異羥肟酸（ｈｙｄｒｏｘａｍｉｃ ａｃｉｄ）衍生物
|
|
US8835472B2
(en)
*
|
2010-09-02 |
2014-09-16 |
Boehringer Ingelheim International Gmbh |
Compounds, pharmaceutical compositions and uses thereof
|
|
WO2012031298A2
(en)
|
2010-09-03 |
2012-03-08 |
Duke University |
Ethynylbenzene derivatives
|
|
JP2014501716A
(ja)
*
|
2010-11-10 |
2014-01-23 |
アカオジェン インコーポレイテッド |
ヒドロキサム酸誘導体および細菌感染の処置におけるその使用
|
|
ES2665988T3
(es)
|
2011-04-15 |
2018-04-30 |
Melinta Therapeutics, Inc. |
Compuestos antimicrobianos y métodos de fabricación y uso de los mismos
|
|
US8883819B2
(en)
|
2011-09-01 |
2014-11-11 |
Irm Llc |
Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
|
|
US20150203444A1
(en)
|
2011-09-12 |
2015-07-23 |
Achaogen, Inc. |
Polymorphs of n-((s)-3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-(((1r,2r)-2-(hydroxymethyl)cyclopropyl)buta-1,3-diynyl)benzamide
|
|
CN102603690A
(zh)
*
|
2012-01-17 |
2012-07-25 |
凯莱英医药集团（天津）股份有限公司 |
一种一锅法制备四氢吡喃-4-甲酸及其衍生物的方法
|
|
GEP201706687B
(en)
|
2012-02-17 |
2017-06-26 |
Millennium Pharmaceuticals Inc (A Delaware Corporation) |
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
|
|
WO2013170030A1
(en)
*
|
2012-05-09 |
2013-11-14 |
Achaogen, Inc. |
Antibacterial agents
|
|
EP2847168A1
(en)
|
2012-05-10 |
2015-03-18 |
Achaogen, Inc. |
Antibacterial agents
|
|
US9196844B2
(en)
*
|
2012-06-01 |
2015-11-24 |
Semiconductor Energy Laboratory Co., Ltd. |
Method of synthesizing pyrazine derivative, and light-emitting element, light-emitting device, electronic device, and lighting device
|
|
US9073921B2
(en)
|
2013-03-01 |
2015-07-07 |
Novartis Ag |
Salt forms of bicyclic heterocyclic derivatives
|
|
WO2014165075A1
(en)
|
2013-03-12 |
2014-10-09 |
Achaogen, Inc. |
Antibacterial agents
|
|
RS58930B1
(sr)
|
2013-03-15 |
2019-08-30 |
Fujifilm Toyama Chemical Co Ltd |
Novi derivati hidroksaminske kiseline ili njihova so
|
|
GB201307233D0
(en)
*
|
2013-04-22 |
2013-05-29 |
Vib Vzw |
Compounds and uses thereof
|
|
EP3016934B1
(en)
|
2013-07-02 |
2018-01-10 |
Millennium Pharmaceuticals, Inc. |
Heteroaryl compounds useful as inhibitors of sumo activating enzyme
|
|
US9908851B2
(en)
|
2013-08-16 |
2018-03-06 |
Duke University |
2-piperidinyl substituted N,3-dihydroxybutanamides
|
|
US10647664B2
(en)
|
2013-08-16 |
2020-05-12 |
Duke University |
Substituted hydroxamic acid compounds
|
|
WO2015024011A2
(en)
|
2013-08-16 |
2015-02-19 |
Duke University |
Antibacterial compounds
|
|
MX2016003046A
(es)
|
2013-09-09 |
2016-09-08 |
Melinta Therapeutics Inc |
Compuestos antimicrobianos y métodos de fabricación y utilización de los mismos.
|
|
AU2014315050A1
(en)
|
2013-09-09 |
2016-03-24 |
Melinta Therapeutics, Inc. |
Antimicrobial compunds and methods of making and using the same
|
|
AR097617A1
(es)
|
2013-09-13 |
2016-04-06 |
Actelion Pharmaceuticals Ltd |
Derivados antibacterianos del 2h-indazol
|
|
JP2016210682A
(ja)
*
|
2013-10-18 |
2016-12-15 |
大正製薬株式会社 |
ヒドロキサム酸誘導体
|
|
JPWO2015056799A1
(ja)
*
|
2013-10-18 |
2017-03-09 |
大正製薬株式会社 |
ヒドロキサム酸誘導体
|
|
JP2016210683A
(ja)
*
|
2013-10-18 |
2016-12-15 |
大正製薬株式会社 |
ヒドロキサム酸誘導体
|
|
PL3083567T3
(pl)
|
2013-12-19 |
2018-08-31 |
Idorsia Pharmaceuticals Ltd |
Przeciwbakteryjne pochodne 1h-indazolu i 1h-indolu
|
|
US9539305B1
(en)
|
2014-03-14 |
2017-01-10 |
Fleurir Abx Llc |
Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
|
|
SG11201609286VA
(en)
*
|
2014-05-16 |
2016-12-29 |
Actelion Pharmaceuticals Ltd |
Antibacterial quinazoline-4(3h)-one derivatives
|
|
AU2015274334B2
(en)
*
|
2014-06-12 |
2020-12-17 |
Cedars-Sinai Medical Center |
Compositions and methods for treating cancers
|
|
KR102491125B1
(ko)
|
2014-07-01 |
2023-01-20 |
다케다 야쿠힌 고교 가부시키가이샤 |
Sumo 활성화 효소의 억제제로서 유용한 헤테로아릴 화합물
|
|
WO2016039432A1
(ja)
|
2014-09-12 |
2016-03-17 |
富山化学工業株式会社 |
新規なヒドロキサム酸誘導体および抗菌性物質を組み合わせて使用する方法
|
|
SG11201701956TA
(en)
|
2014-09-12 |
2017-04-27 |
Toyama Chemical Co Ltd |
Novel pharmaceutical composition containing hydroxamic acid derivative or salt thereof
|
|
CN104327140B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁唑烷酮-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CN104231024B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-肌苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
CN104262433B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-腺苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
CN104341476A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-肌苷型多靶点抗菌化合物及其制法和用途
|
|
CN104341475A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CN105777464B
(zh)
*
|
2014-12-26 |
2020-09-29 |
中国科学院上海药物研究所 |
异羟肟酸衍生物及其制备方法和应用
|
|
JP6208161B2
(ja)
|
2015-02-06 |
2017-10-04 |
信越化学工業株式会社 |
非対称共役ジイン化合物の製造方法及びこれを用いたｚ，ｚ−共役ジエン化合物の製造方法
|
|
AU2016228584A1
(en)
|
2015-03-11 |
2017-10-05 |
Melinta Therapeutics, Inc. |
Antimicrobial compounds and methods of making and using the same
|
|
WO2017083434A1
(en)
|
2015-11-09 |
2017-05-18 |
Forge Therapeutics, Inc. |
Pyrone based compounds for treating bacterial infections
|
|
WO2017083431A2
(en)
|
2015-11-09 |
2017-05-18 |
Forge Therapeutics, Inc. |
Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
|
|
US10781184B2
(en)
*
|
2015-12-08 |
2020-09-22 |
Glaxosmithkline Intellectual Property Development Limited |
Substituted benzazinones as antibacterial compounds
|
|
CN105669750B
(zh)
*
|
2016-03-01 |
2018-04-03 |
中国医学科学院医药生物技术研究所 |
新型锌离子螯合剂及其制备和在抗革兰氏阴性菌感染中的应用
|
|
CN108778273B
(zh)
*
|
2016-03-07 |
2022-06-17 |
默沙东公司 |
二环芳基单环β-内酰胺化合物及其用于治疗细菌感染的用途的方法
|
|
WO2017156071A1
(en)
|
2016-03-09 |
2017-09-14 |
Blade Therapeutics, Inc. |
Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof
|
|
EP3445744B1
(en)
*
|
2016-04-18 |
2021-10-06 |
Vivoryon Therapeutics AG |
Novel inhibitors of meprin alpha and beta
|
|
AU2017257755B2
(en)
|
2016-04-25 |
2021-05-06 |
Duke University |
Benzoylglycine derivatives and methods of making and using same
|
|
JP2019515041A
(ja)
|
2016-05-06 |
2019-06-06 |
メリンタ セラピューティクス、 インコーポレイテッドＭｅｌｉｎｔａ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． |
抗菌剤ならびにそれを作製および使用する方法
|
|
WO2017223349A1
(en)
|
2016-06-23 |
2017-12-28 |
Achaogen, Inc. |
Antibacterial agents
|
|
EP3481835A4
(en)
|
2016-07-05 |
2020-02-26 |
Blade Therapeutics, Inc. |
CALPAIN MODULATORS AND THEIR THERAPEUTIC USES
|
|
WO2018064119A1
(en)
|
2016-09-28 |
2018-04-05 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
JP7082445B2
(ja)
|
2016-12-23 |
2022-06-08 |
インターベット インターナショナル ベー． フェー． |
ウシ又はブタの呼吸器疾患を治療するための化合物
|
|
US11034650B2
(en)
*
|
2016-12-23 |
2021-06-15 |
Intervet Inc. |
Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infection
|
|
MX388196B
(es)
|
2017-04-26 |
2025-03-19 |
Basilea Pharm Int Ag |
Procesos para la preparacion de furazanobencimidazoles y formas cristalinas de estos.
|
|
EP3621962A4
(en)
|
2017-05-10 |
2020-12-09 |
Forge Therapeutics, Inc. |
ANTIBACTERIAL COMPOUNDS
|
|
US20200095236A1
(en)
*
|
2017-05-10 |
2020-03-26 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
JP7266597B2
(ja)
*
|
2017-07-27 |
2023-04-28 |
バイオメンディクス，エルエルシー |
微生物のコロニー形成を抑制するための置換トラン
|
|
WO2019040404A1
(en)
*
|
2017-08-21 |
2019-02-28 |
Microbiotix, Inc. |
METABOLIC-STABLE METABOLIC-N-ACYLAMINOOXADIAZOLES USEFUL AS ANTIBACTERIAL AGENTS
|
|
US11498909B2
(en)
|
2018-02-10 |
2022-11-15 |
Kbp Biosciences Co., Ltd. |
Compound acting as antibiotics
|
|
CN112135825A
(zh)
|
2018-03-13 |
2020-12-25 |
夏尔人类遗传性治疗公司 |
血浆激肽释放酶抑制剂及其用途
|
|
TWI827677B
(zh)
|
2018-09-18 |
2024-01-01 |
美商尼坎醫療公司 |
作為src同源-2磷酸酶抑制劑之稠合三環衍生物
|
|
BR112021005044A2
(pt)
|
2018-09-20 |
2021-06-08 |
Forge Therapeutics, Inc. |
compostos antibacterianos
|
|
PT3873884T
(pt)
|
2018-10-30 |
2025-02-25 |
Gilead Sciences Inc |
Derivados de 3-(quinolin-8-il)-1,4-dihidropirido[3,4-d]pirimidina-2,4-diona como inibidores da integrina alfa4beta7 para o tratamento de doenças inflamatórias
|
|
EP3873900B1
(en)
|
2018-10-30 |
2025-01-08 |
Gilead Sciences, Inc. |
Imidazo[1,2-a]pyridine derivatives as alpha4beta7 integrin inhibitors for the treatment of inflammatory diseases
|
|
WO2020092383A1
(en)
|
2018-10-30 |
2020-05-07 |
Gilead Sciences, Inc. |
Compounds for inhibition of alpha 4 beta 7 integrin
|
|
PL3873605T3
(pl)
|
2018-10-30 |
2025-03-03 |
Gilead Sciences, Inc. |
Związki hamujące integrynę alfa4beta7
|
|
WO2020102572A1
(en)
*
|
2018-11-14 |
2020-05-22 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
AU2019383674A1
(en)
*
|
2018-11-21 |
2021-06-10 |
Taisho Pharmaceutical Co., Ltd. |
Novel imidazole derivative
|
|
EP4013499A1
(en)
|
2019-08-14 |
2022-06-22 |
Gilead Sciences, Inc. |
Compounds for inhibition of alpha 4 beta 7 integrin
|
|
DK4031547T3
(da)
|
2019-09-18 |
2024-09-09 |
Takeda Pharmaceuticals Co |
Plasmakallikreininhibitorer og anvendelser deraf
|
|
CN114667289B
(zh)
|
2019-09-18 |
2025-08-26 |
武田药品工业有限公司 |
杂芳基血浆激肽释放酶抑制剂
|
|
CN110563611B
(zh)
*
|
2019-09-19 |
2021-02-02 |
中国医学科学院医药生物技术研究所 |
一种异羟肟酸类衍生物及其制备方法和应用
|
|
WO2021138391A1
(en)
|
2019-12-30 |
2021-07-08 |
Tyra Biosciences, Inc. |
Indazole compounds
|
|
US11731962B2
(en)
|
2020-03-25 |
2023-08-22 |
Blacksmith Medicines, Inc. |
LpxC inhibitor and methods of making
|
|
CN116096714A
(zh)
|
2020-06-10 |
2023-05-09 |
安力高医药股份有限公司 |
用于治疗冠状病毒、小核糖核酸病毒和诺罗病毒感染的抗病毒化合物
|
|
TN2023000286A1
(en)
|
2021-06-14 |
2025-07-02 |
Scorpion Therapeutics Inc |
Urea derivatives which can be used to treat cancer
|
|
KR20240035513A
(ko)
|
2021-07-09 |
2024-03-15 |
알리고스 테라퓨틱스 인코포레이티드 |
항바이러스 화합물
|
|
WO2023011573A1
(zh)
*
|
2021-08-05 |
2023-02-09 |
浙江海正药业股份有限公司 |
芳香乙炔类衍生物及其制备方法和用途
|
|
US12065428B2
(en)
|
2021-09-17 |
2024-08-20 |
Aligos Therapeutics, Inc. |
Anti-viral compounds
|
|
JP2024536864A
(ja)
|
2021-09-28 |
2024-10-08 |
ブラックスミス メディシンズ，インク． |
Ｌｐｘｃ阻害剤およびその使用
|
|
MX2024007860A
(es)
*
|
2021-12-24 |
2024-07-09 |
Intervet Int Bv |
Proceso de preparacion de derivados de hidroxilamina.
|
|
CN119923396A
(zh)
*
|
2022-09-28 |
2025-05-02 |
浙江海正药业股份有限公司 |
芳香乙炔类衍生物及其制备方法和其医药上的用途
|
|
CN115480037B
(zh)
*
|
2022-10-14 |
2023-07-18 |
青岛国泰检测科技有限公司 |
一种污水检测方法
|
|
CN115598253B
(zh)
*
|
2022-10-25 |
2025-02-21 |
无锡紫杉药业股份有限公司 |
一种多西他赛原料药中dcc和dcu残留的检测方法
|
|
WO2024127350A1
(en)
|
2022-12-16 |
2024-06-20 |
Astrazeneca Ab |
2,6,9-trisubstituted purines
|
|
CN117586278A
(zh)
*
|
2023-11-27 |
2024-02-23 |
华北制药集团先泰药业有限公司 |
一种氨苄西林钠杂质及其制备方法
|
|
WO2025155681A1
(en)
*
|
2024-01-19 |
2025-07-24 |
Corteva Agriscience Llc |
Nitrification inhibiting mixtures
|